Literature DB >> 31217087

Comprehensive comparative analysis of cost-effectiveness and perioperative outcomes between open, laparoscopic, and robotic distal pancreatectomy.

Deepa R Magge1, Mazen S Zenati1, Ahmad Hamad2, Caroline Rieser1, Amer H Zureikat1, Herbert J Zeh3, Melissa E Hogg1.   

Abstract

BACKGROUND: NSQIP data show that half of distal pancreatectomies (DP) are performed by a minimally invasive approach (MIS). Advantages have been demonstrated for MIS DP, yet comparative cost data are limited. Outcomes and cost were compared in patients undergoing open (ODP), laparoscopic (LDP), and robotic (RDP) approaches at a single institution.
METHODS: A retrospective review was performed on patients undergoing DP between 1/2010-5/2016. Analysis was intention-to-treat, and cost was available after 1/2013.
RESULTS: DP was performed in 374 patients: ODP = 85, LDP = 93, and RDP = 196. Operating time was lowest in the RDP cohort (p < 0.0001). ODP had higher estimated blood loss (p < 0.0001) and transfusions (p < 0.0001) than LDP and RDP. LDP had greater conversions to open procedures than RDP (p = 0.001). Postoperative outcomes were similar between groups. Length of stay was higher in the ODP group (p = 0.0001) than LDP and RDP. Overall cost for the ODP was higher than the RDP and LDP group (p = 0.002). On multivariate analysis, RDP reduced LOS (ODP: Odds = 6.5 [p = 0.0001] and LDP: Odds = 2.1 [p = 0.036]) and total cost (ODP: Odds = 5.7 [p = 0.002] and LDP: Odds = 2.8 [p = 0.042]) independently of all demographics and illness covariates.
CONCLUSIONS: A robotic approach is associated with reduced length of stay and cost compared to open and laparoscopic procedures. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 31217087     DOI: 10.1016/j.hpb.2018.05.014

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  7 in total

1.  The issue of the cost of robotic distal pancreatectomies.

Authors:  Benedetto Ielpo; Javier Nuñez-Alfonsel; Maria Victoria Diago; Álvaro Hidalgo; Yolanda Quijano; Emilio Vicente
Journal:  Hepatobiliary Surg Nutr       Date:  2019-12       Impact factor: 7.293

2.  Robotic-assisted versus open distal pancreatectomy for benign and low-grade malignant pancreatic tumors: a propensity score-matched study.

Authors:  Yuanchi Weng; Jiabin Jin; Zhen Huo; Yusheng Shi; Yu Jiang; Xiaxing Deng; Chenghong Peng; Baiyong Shen
Journal:  Surg Endosc       Date:  2020-08-11       Impact factor: 4.584

3.  Robotic versus open pancreatic surgery: a propensity score-matched cost-effectiveness analysis.

Authors:  Christian Benzing; Lea Timmermann; Thomas Winklmann; Lena Marie Haiden; Karl Herbert Hillebrandt; Axel Winter; Max Magnus Maurer; Matthäus Felsenstein; Felix Krenzien; Moritz Schmelzle; Johann Pratschke; Thomas Malinka
Journal:  Langenbecks Arch Surg       Date:  2022-03-21       Impact factor: 2.895

4.  Clinical value and cost-effectiveness of minimally invasive distal pancreatectomy.

Authors:  Andrea Belli; Francesco Izzo; Giulio Belli
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

5.  Up-to-date comparison of robotic-assisted versus open distal pancreatectomy: A PRISMA-compliant meta-analysis.

Authors:  Jiangjiao Zhou; Zhuo Lv; Heng Zou; Li Xiong; Zhongtao Liu; Wenhao Chen; Yu Wen
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

Review 6.  The current status and future directions of robotic pancreatectomy.

Authors:  Kohei Nakata; Masafumi Nakamura
Journal:  Ann Gastroenterol Surg       Date:  2021-03-04

7.  Minimally invasive distal pancreatectomy: a case-matched cost-analysis between robot-assisted surgery and direct manual laparoscopy.

Authors:  Gregorio Di Franco; Andrea Peri; Valentina Lorenzoni; Matteo Palmeri; Niccolò Furbetta; Simone Guadagni; Desirée Gianardi; Matteo Bianchini; Luca Emanuele Pollina; Franca Melfi; Domenica Mamone; Carlo Milli; Giulio Di Candio; Giuseppe Turchetti; Andrea Pietrabissa; Luca Morelli
Journal:  Surg Endosc       Date:  2021-02-03       Impact factor: 4.584

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.